eScholarship
metadata only
UC Comments on FDA Guidance Document: Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices (FDA-2021-D-0368)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- UC Request to FDA to Extend Comment Period for Docket No. FDA-2021-N-0286 for “Protection of Human Subjects and Institutional Review Boards” (September 28, 2022)#629313
- WHO Drug Information 2025, vol. 39, 1 [full issue]#166326
- 30 U.S.C. § 1252 — Initial regulatory procedures#584385
- Evidence-based biomedicine: methodology for research, standardization, and scientific procedural aspects (English Edition)#261683
- The legal status of clinical and ethics policies, codes, and guidelines in medical practice and research.#335588
Record · ID 624288
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive